E6U-95746-64221
2 vaccinations
4 coded responses
16 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 926 / CA
- Registered
- 2021-01-18
- Relationship
- Self
Timeline
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Survey response — day 0, dose 1MedDRA: Asthenopia, Eyelid ptosis, Headache, Immediate post-injection reaction — Feeling: Good · HeadacheFree text: Developed a localized headache about 30 minutes after vaccine. Location over right eye and right side of head. Eye felt heavy and droopy but normal on assessment.This resolved within one hour.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: PainFree text: Injection site warm to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-22
- 2021-01-23
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Injection site mass — Feeling: Good · Site: Redness, SwellingFree text: Someone else just noticed today at my inj. site, small, slightly red raised area, approx. 2 mm. Redness & raised area not noticed before.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-02-01
-
2021-02-08
Dose 2 — Pfizer-BioNTech
- 2021-02-08
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Heaviness in chest, unable to take deep inspirationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-14
- 2021-02-15
- 2021-02-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Developed a localized headache about 30 minutes after vaccine. Location over right eye and right side of head. Eye felt heavy and droopy but normal on assessment.This resolved within one hour.
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site warm to touch
Systemic reaction (other): Someone else just noticed today at my inj. site, small, slightly red raised area, approx. 2 mm. Redness & raised area not noticed before.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Heaviness in chest, unable to take deep inspiration
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Asthenopia | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Eyelid ptosis | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release